Jiyong Park

Jiyong Park

Auto-generated profile, based on publicly available information

Jiyong Park

Department of Chemistry Korea Advanced Institute of Science and Technology (KAIST) Daejeon Republic of Korea

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2012 in Science
Verified
Journal Article
Closed access
PDF file
ALArthur Laganowsky
Arthur Laganowsky
CLCong Liu
Cong Liu
MSMichael R. Sawaya
Michael R. Sawaya
JWJulian P. Whitelegge
Julian P. Whitelegge
JPJiyong Park
Jiyong Park
DEDavid Eisenberg
David Eisenberg
A Toxic Barrel: Many studies have suggested that oligomers are an important toxic species in amyloid diseases such as Alzheimer's disease. In an effort to better define these oligomers, Laganowsky et al. (p. 1228 ) identified a segment of the fibril-forming protein αB crystalline (ABC) that forms both amyloid fibrils and a relatively stable oligomer. ABC oligomers were toxic in a cell viability assay and were recognized by an amyloid-oligomer–specific antibody. A crystal structure of the oligomers showed that six peptides formed an antiparallel barrel termed a cylindrin. Amyloid oligomers are likely to be structurally polymorphic, but cylindrin-like assemblies offer a model for these elusive structures.

3 December 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CLCong Liu
Cong Liu
MZMinglei Zhao
Minglei Zhao
LJLin Jiang
Lin Jiang
PCPin-Nan Cheng
Pin-Nan Cheng
JPJiyong Park
Jiyong Park
DEDavid Eisenberg
David Eisenberg
Although aberrant protein aggregation has been conclusively linked to dozens of devastating amyloid diseases, scientists remain puzzled about the molecular features that render amyloid fibrils or small oligomers toxic. Here, we report a previously unobserved type of amyloid fibril that tests as cytotoxic: one in which the strands of the contributing β-sheets are out of register. In all amyloid fibrils previously characterized at the molecular level, only in-register β-sheets have been observed, in which each strand makes its full complement of hydrogen bonds with the strands above and below it in the fibril. In out-of-register sheets, strands are sheared relative to one another, leaving dangling hydrogen bonds. Based on this finding, we designed out-of-register β-sheet amyloid mimics, which form both cylindrin-like oligomers and fibrils, and these mimics are cytotoxic. Structural and energetic considerations suggest that out-of-register fibrils can readily convert to toxic cylindrins. We propose that out-of-register β-sheets and their related cylindrins are part of a toxic amyloid pathway, which is distinct from the more energetically favored in-register amyloid pathway.

24 September 2018 in Organometallics
Verified
Journal Article
Closed access
Ho Jin RyuHo Jin Ryu
Ho Jin Ryu
JPJiyong Park
Jiyong Park
HKHong Ki Kim
Hong Ki Kim
JPJi Young Park
Ji Young Park
SKSeoung-Tae Kim
Seoung-Tae Kim
MBMu-Hyun Baik
Mu-Hyun Baik

19 February 2015 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
IYIlhan Yavuz
Ilhan Yavuz
BMBlanton N. Martin
Blanton N. Martin
JPJiyong Park
Jiyong Park
KHKendall N Houk
Kendall N Houk

7 December 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ENElizabeth L. Noey
Elizabeth L. Noey
NTNidhi Tibrewal
Nidhi Tibrewal
GJGonzalo Jiménez-Osés
Gonzalo Jiménez-Osés
SOSílvia Osuna
Sílvia Osuna
JPJiyong Park
Jiyong Park
KHKendall N Houk
Kendall N Houk
Mutants of Lactobacillus kefir short-chain alcohol dehydrogenase, used here as ketoreductases (KREDs), enantioselectively reduce the pharmaceutically relevant substrates 3-thiacyclopentanone and 3-oxacyclopentanone. These substrates differ by only the heteroatom (S or O) in the ring, but the KRED mutants reduce them with different enantioselectivities. Kinetic studies show that these enzymes are more efficient with 3-thiacyclopentanone than with 3-oxacyclopentanone. X-ray crystal structures of apo- and NADP+-bound selected mutants show that the substrate-binding loop conformational preferences are modified by these mutations. Quantum mechanical calculations and molecular dynamics (MD) simulations are used to investigate the mechanism of reduction by the enzyme. We have developed an MD-based method for studying the diastereomeric transition state complexes and rationalize different enantiomeric ratios. This method, which probes the stability of the catalytic arrangement within the theozyme, shows a correlation between the relative fractions of catalytically competent poses for the enantiomeric reductions and the experimental enantiomeric ratio. Some mutations, such as A94F and Y190F, induce conformational changes in the active site that enlarge the small binding pocket, facilitating accommodation of the larger S atom in this region and enhancing S-selectivity with 3-thiacyclopentanone. In contrast, in the E145S mutant and the final variant evolved for large-scale production of the intermediate for the antibiotic sulopenem, R-selectivity is promoted by shrinking the small binding pocket, thereby destabilizing the pro-S orientation. Significance Ketoreductases are the most commonly used enzymes in industrial pharmaceutical synthesis. We investigated the nature of enantioselectivity in closely related mutant ketoreductases that reduce almost-symmetrical 3-oxacyclopentanone and 3-thiacyclopentanone, which are difficult to reduce enantioselectively by other means. We present the efficiencies of select variants and their crystallographic structures. Our experimental and theoretical studies reveal how mutations modulate the stereoselectivity of the reduction. Molecular dynamics simulations of the Michaelis–Menten and transition state-bound complexes were used to rationalize the observed stereochemical outcomes. We discovered that the closed conformation of the flexible substrate binding loop is likely the catalytically active one imparting the stereochemical preferences. Our molecular dynamics approach reveals how each enzyme stabilizes the diastereomeric transition structures by altering the active site size.

2 March 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
RHRobert J. Harris
Robert J. Harris
JPJiyong Park
Jiyong Park
TNTaylor A. F. Nelson
Taylor A. F. Nelson
NINafees Iqbal
Nafees Iqbal
DSDaniel C. Salgueiro
Daniel C. Salgueiro
SBSimon B. Blakey
Simon B. Blakey